Literature DB >> 21093170

Vaginal motion and bladder and rectal volumes during pelvic intensity-modulated radiation therapy after hysterectomy.

Anuja Jhingran1, Mohammad Salehpour, Marianne Sam, Larry Levy, Patricia J Eifel.   

Abstract

PURPOSE: To evaluate variations in bladder and rectal volume and the position of the vaginal vault during a 5-week course of pelvic intensity-modulated radiation therapy (IMRT) after hysterectomy. METHODS AND MATERIALS: Twenty-four patients were instructed how to fill their bladders before simulation and treatment. These patients underwent computed tomography simulations with full and empty bladders and then underwent rescanning twice weekly during IMRT; patients were asked to have full bladder for treatment. Bladder and rectal volumes and the positions of vaginal fiducial markers were determined, and changes in volume and position were calculated.
RESULTS: The mean full and empty bladder volumes at simulation were 480 cc (range, 122-1,052) and 155 cc (range, 49-371), respectively. Bladder volumes varied widely during IMRT: the median difference between the maximum and minimum volumes was 247 cc (range, 96-585). Variations in rectal volume during IMRT were less pronounced. For the 16 patients with vaginal fiducial markers in place throughout IMRT, the median maximum movement of the markers during IMRT was 0.59 cm in the right-left direction (range, 0-0.9), 1.46 cm in the anterior-posterior direction (range, 0.8-2.79), and 1.2 cm in the superior-inferior direction (range, 0.6-2.1). Large variations in rectal or bladder volume frequently correlated with significant displacement of the vaginal apex.
CONCLUSION: Although treatment with a full bladder is usually preferred because of greater sparing of small bowel, our data demonstrate that even with detailed instruction, patients are unable to maintain consistent bladder filling. Variations in organ position during IMRT can result in marked changes in the position of the target volume and the volume of small bowel exposed to high doses of radiation.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093170     DOI: 10.1016/j.ijrobp.2010.08.024

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  16 in total

1.  Radioluminescence characterization of in situ x-ray nanodosimeters: Potential real-time monitors and modulators of external beam radiation therapy.

Authors:  Jeffrey S Souris; Shih-Hsun Cheng; Charles Pelizzari; Nai-Tzu Chen; Patrick La Riviere; Chin-Tu Chen; Leu-Wei Lo
Journal:  Appl Phys Lett       Date:  2014-11-20       Impact factor: 3.791

2.  Vaginal displacement during course of adjuvant radiation for cervical cancer: results from a prospective IG-IMRT study.

Authors:  S Chopra; A Patidar; T Dora; N Moirangthem; S N Paul; R Engineer; U Mahantshetty; S K Shrivastava
Journal:  Br J Radiol       Date:  2014-08-19       Impact factor: 3.039

3.  An assessment of interfractional bladder, rectum and vagina motion in postoperative cervical cancer based on daily cone-beam computed tomography.

Authors:  Xin Wang; Min Yu; Jin Wang; Renming Zhong; Yali Shen; Yaqin Zhao; Zhiping Li; Sen Bai; Feng Xu
Journal:  Mol Clin Oncol       Date:  2015-12-10

4.  Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203.

Authors:  Ann H Klopp; Anamaria R Yeung; Snehal Deshmukh; Karen M Gil; Lari Wenzel; Shannon N Westin; Kent Gifford; David K Gaffney; William Small; Spencer Thompson; Desiree E Doncals; Guilherme H C Cantuaria; Brian P Yaremko; Amy Chang; Vijayananda Kundapur; Dasarahally S Mohan; Michael L Haas; Yong Bae Kim; Catherine L Ferguson; Stephanie L Pugh; Lisa A Kachnic; Deborah W Bruner
Journal:  J Clin Oncol       Date:  2018-07-10       Impact factor: 44.544

5.  Internal target volume for post-hysterectomy vaginal recurrences of cervical cancers during image-guided radiotherapy.

Authors:  Maheshkumar N Upasani; Supriya Chopra; Reena Engineer; Umesh Mahantshetty; Seema Medhi; Zubin Mehta; Shyam K Shrivastava
Journal:  Br J Radiol       Date:  2015-08-07       Impact factor: 3.039

6.  Does ITV vaginal procedure ensure dosimetric coverage during IMRT of post-operative gynaecological tumours without instructions concerning rectal filling?

Authors:  Ramona Verges; Alexandra Giraldo; Alejandro Seoane; Elisabet Toral; M Carmen Ruiz; Ariadna Pons; Jordi Giralt
Journal:  Rep Pract Oncol Radiother       Date:  2018-03-02

7.  NRG Oncology/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update.

Authors:  William Small; Walter R Bosch; Mathew M Harkenrider; Jonathan B Strauss; Nadeem Abu-Rustum; Kevin V Albuquerque; Sushil Beriwal; Carien L Creutzberg; Patricia J Eifel; Beth A Erickson; Anthony W Fyles; Courtney L Hentz; Anuja Jhingran; Ann H Klopp; Charles A Kunos; Loren K Mell; Lorraine Portelance; Melanie E Powell; Akila N Viswanathan; Joseph H Yacoub; Catheryn M Yashar; Kathryn A Winter; David K Gaffney
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-09-06       Impact factor: 7.038

8.  Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer.

Authors:  Katsutomo Tsujii; Yoshihiro Ueda; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima; Masahiko Koizumi
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

9.  Vaginal cuff brachytherapy: do we need to treat to more than a two-centimeter active length?

Authors:  Garrett L Jensen; Parul N Barry; Harriet Eldredge-Hindy; Scott R Silva; Sarah L Todd; Kendall P Hammonds; Walker R Zimmerman; Daniel S Metzinger; Moataz N El-Ghamry
Journal:  J Contemp Brachytherapy       Date:  2021-05-07

10.  Dynamic Changes in Bladder Morphology Over Time in Cervical Cancer Patients.

Authors:  Fu Jin; Qiang Liu; Huanli Luo; Rui Zhu; Yanhong Mou; Yongzhong Wu; Ying Wang
Journal:  Cancer Control       Date:  2021 Jan-Dec       Impact factor: 3.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.